Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125641871 | 12564187 | 1 | I | 20160711 | 20160718 | 20160718 | EXP | AU-DEPOMED, INC.-AU-2016DEP011462 | DEPOMED | CHIEW A. SUB-MAMMARY INJECTION OF ROPIVACAINE RESULTING IN SEVERE TOXICITY WITH SEIZURES. EMERG MED AUSTRALAS. 2016;28(2):246-247 | 37.00 | YR | F | Y | 54.00000 | KG | 20160715 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125641871 | 12564187 | 1 | PS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | UNK | 22569 | ||||||||||
| 125641871 | 12564187 | 2 | SS | ROPIVACAINE | ROPIVACAINE | 1 | 200 MG DILUTED IN 200 ML NORMAL SALINE, 3.7 MG/KG | 0 | 200 | MG | |||||||||
| 125641871 | 12564187 | 3 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | 3 MG, UNK | 0 | 3 | MG | |||||||||
| 125641871 | 12564187 | 4 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125641871 | 12564187 | 5 | SS | DEXMEDETOMIDINE. | DEXMEDETOMIDINE | 1 | UNK | 0 | |||||||||||
| 125641871 | 12564187 | 6 | SS | PROPOFOL. | PROPOFOL | 1 | UNK | 0 | |||||||||||
| 125641871 | 12564187 | 7 | C | ADRENALINE /00003901/ | EPINEPHRINE | 1 | 1 MG DILUTED IN 200 ML NORMAL SALINE | 0 | 1 | MG | |||||||||
| 125641871 | 12564187 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Intravenous (not otherwise specified) | 1 G, UNK | 0 | 1 | G | ||||||||
| 125641871 | 12564187 | 9 | C | CEPHAZOLIN | CEFAZOLIN | 1 | UNK | 0 | |||||||||||
| 125641871 | 12564187 | 10 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 8 MG, UNK | 0 | 8 | MG | ||||||||
| 125641871 | 12564187 | 11 | C | ONDANSETRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125641871 | 12564187 | 1 | Sedative therapy |
| 125641871 | 12564187 | 2 | Induction of anaesthesia |
| 125641871 | 12564187 | 3 | Sedation |
| 125641871 | 12564187 | 5 | Sedative therapy |
| 125641871 | 12564187 | 6 | Sedative therapy |
| 125641871 | 12564187 | 7 | Induction of anaesthesia |
| 125641871 | 12564187 | 8 | Product used for unknown indication |
| 125641871 | 12564187 | 9 | Product used for unknown indication |
| 125641871 | 12564187 | 10 | Product used for unknown indication |
| 125641871 | 12564187 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125641871 | 12564187 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125641871 | 12564187 | Agitation | |
| 125641871 | 12564187 | Anxiety | |
| 125641871 | 12564187 | Generalised tonic-clonic seizure | |
| 125641871 | 12564187 | Malaise | |
| 125641871 | 12564187 | Paraesthesia oral | |
| 125641871 | 12564187 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |